Aarti Drugs Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.8%1-day move

₹380.05

prior close

₹391.00

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.1-0.3-0.6—+3.8+3.3+3.0-0.3+0.9-0.4-1.1-1.3+8.7—

Up moveDown movePending

AI summary

Aarti Drugs Limited has disclosed a scheduled investor meeting for 27th May 2026 from 10:00 AM to 1:00 PM at Grand Hyatt, Mumbai. The meeting is organised by 360 ONE Capital (B&K) and will include 1x1 and group meetings with investors/analysts. The company has explicitly stated that discussions will be based solely on publicly available information and that no Unpublished Price Sensitive Information (UPSI) will be shared during the interactions. The filing is made under SEBI Regulation 30(6) of the Listing Obligations and Disclosure Requirements Regulations, 2015.

Likely market impact

The meeting is routine investor engagement activity. No new material information is expected to be disclosed, and the explicit UPSI disclaimer minimises any trading risk. The event signals management's continued engagement with the investor community.